What is Catalyst Pharmaceutical's revenue?

Catalyst Pharmaceutical (CPRX) generated $597.0M in revenue over the trailing twelve months, up 11.7% year over year.

Is Catalyst Pharmaceutical profitable?

Catalyst Pharmaceutical reported $221.3M in net income over the trailing twelve months, a 37.1% net margin.

What are Catalyst Pharmaceutical's profit margins?

Gross margin is 86.0% and operating margin is 44.8%, with a 37.1% net margin.

What is Catalyst Pharmaceutical's earnings per share?

Catalyst Pharmaceutical's diluted EPS over the trailing twelve months is $1.74.

Where does Catalyst Pharmaceutical's income statement data come from?

Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$596.96M+1.4%	$588.99M+1.9%	$578.2M+3.5%	$558.5M+4.5%	$534.65M+8.7%
Total cost of revenue	$83.82M-3.9%	$87.25M+5.4%	$82.82M+4.3%	$79.45M+7.0%	$74.24M+7.8%
Gross profit	$513.14M+2.3%	$501.74M+1.3%	$495.37M+3.4%	$479.05M+4.0%	$460.41M+8.9%
Gross margin	86%+0.8pp	85.2%-0.5pp	85.7%-0.1pp	85.8%-0.3pp	86.1%+0.1pp
Research and development	$11.48M-9.6%	$12.71M-13.5%	$14.7M-4.1%	$15.33M+9.8%	$13.95M+10.3%
Selling, general and administrative	$196.16M+1.2%	$193.75M+5.0%	$184.52M+0.9%	$182.93M+2.9%	$177.71M0.0%
Operating income	$267.64M+3.8%	$257.78M-0.4%	$258.78M+6.3%	$243.42M+5.2%	$231.37M+18.6%
Operating margin	44.8%+1.1pp	43.8%-1.0pp	44.8%+1.2pp	43.6%+0.3pp	43.3%+3.6pp
Other income (expense), net	$28.82M+12.0%	$25.74M-4.7%	$27.02M-5.4%	$28.55M+5.4%	$27.1M+28.2%
Income before income taxes	$296.46M+4.6%	$283.52M-0.8%	$285.8M+5.1%	$271.97M+5.2%	$258.46M+19.5%
Income tax expense	$75.14M+8.6%	$69.19M+1.4%	$68.23M+7.8%	$63.3M+3.6%	$61.11M+16.7%
Net income	$221.32M+3.3%	$214.33M-1.5%	$217.56M+4.3%	$208.67M+5.7%	$197.35M+20.4%
Net margin	37.1%+0.7pp	36.4%-1.2pp	37.6%+0.3pp	37.4%+0.4pp	36.9%+3.6pp
Diluted earnings per share	$1.74+3.0%	$1.69-1.7%	$1.72+4.2%	$1.65+5.1%	$1.57+19.8%
EBITDA	$305.83M+3.4%	$295.65M-0.3%	$296.57M+5.4%	$281.25M+4.5%	$269.17M+15.6%
EBITDA margin	51.2%+1.0pp	50.2%-1.1pp	51.3%+0.9pp	50.4%0.0pp	50.3%+3.0pp
EBIT	$267.64M+3.8%	$257.78M-0.4%	$258.78M+6.3%	$243.42M+5.2%	$231.37M+18.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Catalyst Pharmaceutical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's revenue?: Catalyst Pharmaceutical (CPRX) generated $597.0M in revenue over the trailing twelve months, up 11.7% year over year.
Is Catalyst Pharmaceutical profitable?: Catalyst Pharmaceutical reported $221.3M in net income over the trailing twelve months, a 37.1% net margin.
What are Catalyst Pharmaceutical's profit margins?: Gross margin is 86.0% and operating margin is 44.8%, with a 37.1% net margin.
What is Catalyst Pharmaceutical's earnings per share?: Catalyst Pharmaceutical's diluted EPS over the trailing twelve months is $1.74.
Where does Catalyst Pharmaceutical's income statement data come from?: Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.